Literature DB >> 22753953

Mechanisms of triglyceride accumulation in activated macrophages.

Kenneth R Feingold1, Judy K Shigenaga, Mahmood R Kazemi, Carol M McDonald, Sophie M Patzek, Andrew S Cross, Arthur Moser, Carl Grunfeld.   

Abstract

LPS treatment of macrophages induces TG accumulation, which is accentuated by TG-rich lipoproteins or FFA. We defined pathways altered during macrophage activation that contribute to TG accumulation. Glucose uptake increased with activation, accompanied by increased GLUT1. Oxidation of glucose markedly decreased, whereas incorporation of glucose-derived carbon into FA and sterols increased. Macrophage activation also increased uptake of FFA, associated with an increase in CD36. Oxidation of FA was markedly reduced, whereas the incorporation of FA into TGs increased, associated with increased GPAT3 and DGAT2. Additionally, macrophage activation decreased TG lipolysis; however, expression of ATGL or HSL was not altered. Macrophage activation altered gene expression similarly when incubated with exogenous FA or AcLDL. Whereas activation with ligands of TLR2 (zymosan), TLR3 (poly I:C), or TLR4 (LPS) induced alterations in macrophage gene expression, leading to TG accumulation, treatment of macrophages with cytokines had minimal effects. Thus, activation of TLRs leads to accumulation of TG in macrophages by multiple pathways that may have beneficial effects in host defense but could contribute to the accelerated atherosclerosis in chronic infections and inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753953      PMCID: PMC3441312          DOI: 10.1189/jlb.1111537

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  55 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

2.  Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses.

Authors:  Amer A Beg
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

Review 3.  Innate immune responses to microbial poisons: discovery and function of the Toll-like receptors.

Authors:  Bruce Beutler
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

Review 4.  Critical roles of Toll-like receptors in host defense.

Authors:  T Kaisho; S Akira
Journal:  Crit Rev Immunol       Date:  2000       Impact factor: 2.214

5.  Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet.

Authors:  H A Lehr; T A Sagban; C Ihling; U Zähringer; K D Hungerer; M Blumrich; K Reifenberg; S Bhakdi
Journal:  Circulation       Date:  2001-08-21       Impact factor: 29.690

6.  Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation.

Authors:  Maria A Ostos; Delia Recalde; Mario M Zakin; Daniel Scott-Algara
Journal:  FEBS Lett       Date:  2002-05-22       Impact factor: 4.124

7.  Toll-like receptor 4 polymorphisms and atherogenesis.

Authors:  Stefan Kiechl; Eva Lorenz; Markus Reindl; Christian J Wiedermann; Friedrich Oberhollenzer; Enzo Bonora; Johann Willeit; David A Schwartz
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

8.  Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events.

Authors:  Nejma Ameziane; Tiphaine Beillat; Patrice Verpillat; Sylvie Chollet-Martin; Marie-Claude Aumont; Patrick Seknadji; Maryse Lamotte; Dominique Lebret; Véronique Ollivier; Dominique de Prost
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-16       Impact factor: 8.311

Review 9.  Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis.

Authors:  Fredric B Kraemer; Wen-Jun Shen
Journal:  J Lipid Res       Date:  2002-10       Impact factor: 5.922

10.  pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque.

Authors:  Morteza Naghavi; Reji John; Sameh Naguib; Mir Said Siadaty; Roxana Grasu; K C Kurian; W Barry van Winkle; Babs Soller; Silvio Litovsky; Mohammad Madjid; James T Willerson; Ward Casscells
Journal:  Atherosclerosis       Date:  2002-09       Impact factor: 5.162

View more
  82 in total

Review 1.  A guide to immunometabolism for immunologists.

Authors:  Luke A J O'Neill; Rigel J Kishton; Jeff Rathmell
Journal:  Nat Rev Immunol       Date:  2016-07-11       Impact factor: 53.106

2.  Regulatory role of Gpr84 in the switch of alveolar macrophages from CD11blo to CD11bhi status during lung injury process.

Authors:  Chengcong Yin; Long Cheng; Jiajia Pan; Lili Chen; Qi Xue; Juliang Qin; Shaoying Wang; Bing Du; Mingyao Liu; Ying Zhang; Wenzheng Jiang; Min Qian; Hua Ren
Journal:  Mucosal Immunol       Date:  2020-07-27       Impact factor: 7.313

Review 3.  Role of the steroidogenic acute regulatory protein in health and disease.

Authors:  Pulak R Manna; Cloyce L Stetson; Andrzej T Slominski; Kevin Pruitt
Journal:  Endocrine       Date:  2015-08-14       Impact factor: 3.633

4.  Acetate treatment increases fatty acid content in LPS-stimulated BV2 microglia.

Authors:  Dhaval P Bhatt; Thad A Rosenberger
Journal:  Lipids       Date:  2014-05-23       Impact factor: 1.880

5.  Choline transport links macrophage phospholipid metabolism and inflammation.

Authors:  Shayne A Snider; Kaitlyn D Margison; Peyman Ghorbani; Nicholas D LeBlond; Conor O'Dwyer; Julia R C Nunes; Thao Nguyen; Hongbin Xu; Steffany A L Bennett; Morgan D Fullerton
Journal:  J Biol Chem       Date:  2018-06-07       Impact factor: 5.157

6.  SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism.

Authors:  Yumiko Oishi; Nathanael J Spann; Verena M Link; Evan D Muse; Tobias Strid; Chantle Edillor; Matthew J Kolar; Takashi Matsuzaka; Sumio Hayakawa; Jenhan Tao; Minna U Kaikkonen; Aaron F Carlin; Michael T Lam; Ichiro Manabe; Hitoshi Shimano; Alan Saghatelian; Christopher K Glass
Journal:  Cell Metab       Date:  2016-12-29       Impact factor: 27.287

7.  TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation.

Authors:  Bart Everts; Eyal Amiel; Stanley Ching-Cheng Huang; Amber M Smith; Chih-Hao Chang; Wing Y Lam; Veronika Redmann; Tori C Freitas; Julianna Blagih; Gerritje J W van der Windt; Maxim N Artyomov; Russell G Jones; Erika L Pearce; Edward J Pearce
Journal:  Nat Immunol       Date:  2014-02-23       Impact factor: 25.606

8.  Glycolytic reprogramming of macrophages activated by NOD1 and TLR4 agonists: No association with proinflammatory cytokine production in normoxia.

Authors:  Nina E Murugina; Anna S Budikhina; Yulia A Dagil; Polina V Maximchik; Lyudmila S Balyasova; Vladimir V Murugin; Mikhail V Melnikov; Viktoriya S Sharova; Anna M Nikolaeva; Georgy Z Chkadua; Boris V Pinegin; Mikhail V Pashenkov
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

9.  Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness.

Authors:  Ratanesh Kumar Seth; Diana Kimono; Firas Alhasson; Sutapa Sarkar; Muayad Albadrani; Stephen K Lasley; Ronnie Horner; Patricia Janulewicz; Mitzi Nagarkatti; Prakash Nagarkatti; Kimberly Sullivan; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2018-05-09       Impact factor: 4.219

10.  Circulating Blood Monocyte Subclasses and Lipid-Laden Adipose Tissue Macrophages in Human Obesity.

Authors:  Tal Pecht; Yulia Haim; Nava Bashan; Hagit Shapiro; Ilana Harman-Boehm; Boris Kirshtein; Karine Clément; Iris Shai; Assaf Rudich
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.